(Circulation. 2000;102:1264.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men
From the Department of Medicine, University of Western Australia, and The West Australian Heart Research Institute, Perth, Australia.
Correspondence to Dr Trevor A Mori, University Department of Medicine, Box X2213 GPO, Perth, Western Australia 6847, Australia. E-mail tmori{at}cyllene.uwa.edu.au
Background—Recent evidence
supports differential effects of
eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA), the 2 major 
3 fatty acids of marine origin, on blood
pressure in humans and vascular reactivity in adult
spontaneously hypertensive rats. We investigated possible differences
in the effects of purified EPA or DHA on forearm vascular reactivity in
overweight hyperlipidemic men that might contribute to
the blood pressure–lowering effects of fish oils.
Methods and Results—With a double-blind, placebo-controlled trial of parallel design, 59 overweight, mildly hyperlipidemic men were randomized to receive 4 g/d purified EPA, DHA, or olive oil (placebo) capsules while continuing their usual diets for 6 weeks. Forearm blood flow (FBF) was measured with venous occlusion, strain-gauge plethysmography during the sequential intra-arterial administration of acetylcholine (7.5, 15, and 30 µg/min), sodium nitroprusside (1.5, 3, and 10 µg/min), norepinephrine (10, 20, and 40 ng/min), a single-dose infusion of NG-monomethyl-L-arginine (L-NMMA) (1 mg/min), and coinfusion of acetylcholine (7.5, 15, and 30 µg/min) and L-NMMA. Forty of the 56 subjects who completed the study underwent FBF measurements. Plasma phospholipid EPA levels increased significantly (P<0.0001) after supplementation with EPA, and DHA composition increased with DHA supplementation (P<0.0001). Relative to placebo, DHA, but not EPA, supplementation significantly improved FBF in response to acetylcholine infusion (P=0.040) and coinfusion of acetylcholine with L-NMMA (P=0.040). Infusion of L-NMMA alone showed no group differences. DHA significantly enhanced dilatory responses to sodium nitroprusside (P<0.0001) and attenuated constrictor responses to norepinephrine (P=0.017).
Conclusions—Relative to placebo, DHA, but not EPA, enhances vasodilator mechanisms and attenuates constrictor responses in the forearm microcirculation. Improvements in endothelium-independent mechanisms appear to be predominant and may contribute to the selective blood pressure–lowering effect observed with DHA compared with EPA in humans.
Key Words: fish oils • vasculature • blood pressure • nitric oxide • microcirculation
This article has been cited by other articles:
 |
|
 |
|
  J. W. Fetterman Jr. and M. M. Zdanowicz Therapeutic potential of n-3 polyunsaturated fatty acids in disease Am. J. Health Syst. Pharm., July 1, 2009; 66(13): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S A Wright, F M O'Prey, M T McHenry, W J Leahey, A B Devine, E M Duffy, D G Johnston, M B Finch, A L Bell, and G E McVeigh A randomised interventional trial of {omega}-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus Ann Rheum Dis, June 1, 2008; 67(6): 841 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande Signaling pathways modulated by fish oil in salt-sensitive hypertension Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1323 - F1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Hall, K. A. Sanders, T. A. B. Sanders, and P. J. Chowienczyk A High-Fat Meal Enriched with Eicosapentaenoic Acid Reduces Postprandial Arterial Stiffness Measured by Digital Volume Pulse Analysis in Healthy Men J. Nutr., February 1, 2008; 138(2): 287 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Hamilton, G. T Chew, and G. F Watts Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 89 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 A. M Hill, J. D Buckley, K. J Murphy, and P. R. Howe Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Theobald, A. H. Goodall, N. Sattar, D. C. S. Talbot, P. J. Chowienczyk, and T. A. B. Sanders Low-Dose Docosahexaenoic Acid Lowers Diastolic Blood Pressure in Middle-Aged Men and Women J. Nutr., April 1, 2007; 137(4): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shimojo, S. Jesmin, S. Zaedi, S. Maeda, M. Soma, K. Aonuma, I. Yamaguchi, and T. Miyauchi Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta1 and phosphorylated JNK Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H835 - H845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L Breslow n-3 Fatty acids and cardiovascular disease Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1477 - 1482S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Monahan, T. E. Wilson, and C. A. Ray Omega-3 Fatty Acid Supplementation Augments Sympathetic Nerve Activity Responses to Physiological Stressors in Humans Hypertension, November 1, 2004; 44(5): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. I. O'Connor, L. M. Lawrence, A. C. St. Lawrence, K. M. Janicki, L. K. Warren, and S. Hayes The effect of dietary fish oil supplementation on exercising horses J Anim Sci, October 1, 2004; 82(10): 2978 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ros, I. Nunez, A. Perez-Heras, M. Serra, R. Gilabert, E. Casals, and R. Deulofeu A Walnut Diet Improves Endothelial Function in Hypercholesterolemic Subjects: A Randomized Crossover Trial Circulation, April 6, 2004; 109(13): 1609 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, D. Li, G. J Roberts, T. Saldeen, and J. L Mehta Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes Cardiovasc Res, July 1, 2003; 59(1): 7 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J S Forsyth, P Willatts, C Agostoni, J Bissenden, P Casaer, and G Boehm Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial BMJ, May 3, 2003; 326(7396): 953 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Engler, M. B. Engler, D. M. Pierson, L. B. Molteni, and A. Molteni Effects of Docosahexaenoic Acid on Vascular Pathology and Reactivity in Hypertension Experimental Biology and Medicine, March 1, 2003; 228(3): 299 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): e20 - 30. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, J. D. Best, and L. J. Beilin Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients Diabetes Care, January 1, 2003; 26(1): 253 - 253. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Circulation, November 19, 2002; 106(21): 2747 - 2757. [Full Text] [PDF]
|
|
|
|
|
|
R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.-C. Lee, and M. VanRollins Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 768 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Fegan, K. M. Macleod, J. E. Tooke, and A. C. Shore n-3 NEFA: vascular implications Eur. Heart J., February 1, 2002; 23(3): 185 - 187. [Full Text] [PDF]
|
|